Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
03/30/2023* 08:00 EST Earnings Call Q4 2022 -- -- --
03/30/2023* -- Results Q4 2022 -- 8.57 --
11/07/2022 08:00 EST Earnings Call Q3 2022 -- -- --
11/07/2022 -- Results Q3 2022 6.93 3.39 104.3%
08/08/2022 08:00 EST Earnings Call Q2 2022 -- -- --
08/08/2022 -- Results Q2 2022 6.56 7.19 -8.76%
05/09/2022 08:00 EST Earnings Call Q1 2022 -- -- --
05/09/2022 -- Results Q1 2022 15.00 9.62 55.85%
*Estimated Date/Time

Earnings

Next Report Date 03/30/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/07/2022
Beat/Miss Upgrade
Return Since -11.61%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 30, 2023 (est.)
Last Earnings Release Nov. 07, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. 2.132
Dividend Frequency Annually
Last Ex-Dividend Date Jun. 02, 2022
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 4.30%
Cash Payout Ratio 3.96%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
--
--
--
--
140.6%
216.2%
-40.95%
-5.43%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
-84.98%
-1.59%
48.39%
-89.18%
2.70K%
28.30%
-92.81%
9.24%
-15.87%
33.20%
13.79%
35.65%
3.20%
19.72%
19.22%
-6.43%
4.68%
16.13%
25.06%
-6.73%
3.51%
66.74%
-10.42%
-13.22%
--
--
--
--
--
-57.68%
-82.42%
83.42%
As of February 03, 2023.

Profile

Edit
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 30, 2023 (est.)
Last Earnings Release Nov. 07, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
GNOM 9.063M USD 3.91%
BBH 20.73M USD 3.86%
F00001DVDD 369181.0 USD 3.69%
F00001EN98 366683.0 USD 3.67%
IDNA 5.926M USD 3.54%
FBT 50.63M USD 3.29%
FNRTYX 320251.0 USD 3.20%
BGLFX 16.17M USD 3.18%
POAGX 192.00M USD 2.85%
IBB 213.26M USD 2.34%
VHCOX 285.76M USD 1.69%
HQL 5.586M USD 1.42%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BNTX Tweets